Abstract
Purpose
The Sino-Nasal-Outcome-Test 22 (SNOT-22) questionnaire assesses treatment outcome and health-related quality of life (HRQOL) in patients with chronic rhinosinusitis (CRS). However, given the overlap between CRS and olfaction in terms of nasal function and the definition of CRS, a fundamental question arises: can patients with olfactory dysfunction (OD) stemming from other causes attain SNOT-22 scores similar to those seen in CRS, even in the absence of CRS? Our study aimed to explore whether OD arising from various postinfectious mechanisms challenges the disease-specificity of SNOT-22 for CRS. If so, could focus on scores within specific symptom domains of SNOT-22 prove valuable in distinguishing between different etiologies.
Methods
The study adopted an observational, retrospective cohort design based on prospectively registered patients and related variables using the REDCap platform. 460 patients experiencing OD due to either (1) simple or (2) complex post-COVID-19, (3) postinfectious non-COVID-19, and (4) CRS, were included in the analysis.
Results
The study revealed that the total SNOT-22 score lacks disease-specificity for CRS. This is evident, because complex postinfectious mechanisms resulting from COVID-19 can produce similar symptoms in patients. Notably, elevated total scores were primarily driven by high subdomain scores within the “sleep and cognition” domain.
Conclusions
The application of SNOT-22 as a screening tool needs to be approached with caution, as the total score alone does not provide disease-specific insights. A more thorough exploration of the four symptom domains and the identification of distinctive scoring patterns within the clinical context may prove pivotal in effectively differentiating between various underlying causes.
Similar content being viewed by others
Data availability
Raw data are not publicly available to preserve individuals’ privacy under the European General Data Protection Regulation.
References
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 34(5):447–454. https://doi.org/10.1111/j.1749-4486.2009.01995.x
Stankevice D, Fjaeldstad AW, Agergaard J, Ovesen T (2023) Long-term COVID-19 smell and taste disorders differ significantly from other post-infectious cases. Laryngoscope 133(1):169–174. https://doi.org/10.1002/lary.30453
Dejaco D et al (2019) The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol 276(5):1355–1365. https://doi.org/10.1007/s00405-019-05320-z
Addison AB et al (2021) Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction. J Allergy Clin Immunol 147(5):1704–1719. https://doi.org/10.1016/j.jaci.2020.12.641
Damm M et al (2004) Riechstörungen. Epidemiologie und Therapie in Deutschland, Österreich und der Schweiz [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. HNO 52(2):112–120. https://doi.org/10.1007/s00106-003-0877-z
Fonteyn S, Huart C, Deggouj N, Collet S, Eloy P, Rombaux P (2014) Non-sinonasal-related olfactory dysfunction: a cohort of 496 patients. Eur Ann Otorhinolaryngol Head Neck Dis 131(2):87–91. https://doi.org/10.1016/j.anorl.2013.03.006
Fjaeldstad A, Stankovic J, Onat M, Stankevice D, Ovesen T (2020) Patients and experiences from the first danishflavour clinic. Dan Med J 67(4):1–5
Lopez-Leon S et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. https://doi.org/10.1038/s41598-021-95565-8
Boscolo-Rizzo P, Tofanelli M, Zanelli E, Gardenal N, Tirelli G (2023) COVID-19-related quantitative and qualitative olfactory and gustatory dysfunction: long-term prevalence and recovery rate. ORL J Otolaryngol Relat Spec 85(2):67–71. https://doi.org/10.1159/000525861
Alkodaymi MS et al (2022) Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 28(5):657–666. https://doi.org/10.1016/j.cmi.2022.01.014
Tan HQM, Pendolino AL, Andrews PJ, Choi D (2022) Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2021-054598
Toma S, Hopkins C (2016) Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology 54(2):129–133. https://doi.org/10.4193/Rhino15.072
Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S (2015) Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry. https://doi.org/10.1186/s12888-015-0529-3
Danish Health Authority (2023) Danish Smoking Habits 2022
Danish Health Authority (2022) Danskernes sundhed: Den Nationale Sundhedsprofil 2021—centrale udfordringer [Online]. www.sst.dk
Whitcroft KL, Altundag A, Balungwe P, Boscolo-Rizzo P (2023) Position paper on olfactory dysfunction: 2023. Rhinology. https://doi.org/10.4193/Rhin22.483
Farhood Z, Schlosser RJ, Pearse ME, Storck KA, Nguyen SA, Soler ZM (2016) Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review. Int Forum Allergy Rhinol 6(3):271–277. https://doi.org/10.1002/alr.21668
Nanayakkara JP, Igwe C, Roberts D, Hopkins C (2013) The impact of mental health on chronic rhinosinusitis symptom scores. Eur Arch Otorhinolaryngol 270(4):1361–1364. https://doi.org/10.1007/s00405-012-2230-1
Yim MT, Orlandi RR, Oakley GM, Alt JA (2021) The Sinonasal Outcome Test (SNOT-22) is a poor diagnostic tool for chronic rhinosinusitis. Ann Otol Rhinol Laryngol 130(11):1220–1227. https://doi.org/10.1177/0003489421998213
Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ (2023) Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open. https://doi.org/10.1016/j.ajmo.2023.100033
Acknowledgements
Aparna Udupi and Bo Martin Bibby, Institute for Biostatistics, Aarhus University College.
Funding
None.
Author information
Authors and Affiliations
Contributions
MEH conceptualization, formal analysis, writing—original draft. PRM data curation—review and editing. AWF data curation, software—review and editing. TO conceptualization, methodology, visualization, supervision—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hildebrandt, M.E., Møller, P.R., Fjældstad, A.W. et al. Postinfectious conditions challenge disease-specificity of SNOT-22. Eur Arch Otorhinolaryngol 281, 2395–2402 (2024). https://doi.org/10.1007/s00405-023-08385-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08385-z